SHPH · Shuttle Pharmaceuticals Holdings, Inc.
$5.32
-0.24 (-4.23%)
At close · Oct 9
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 24, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The successful completion of the acquisition or any other acquisition, or such financing, however, cannot be guaranteed. These conditions raise substantial doubt about our ability to continue as a going concern within one year after the date that the consolidated financial statements contained in this report are issued.”View the 10-Q filed Sep 24, 2026
Market Cap
$26.44M
Shares
4.76M
Volume · Oct 9
15.2K
Avg daily vol (3M)
1.35M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.55
Open$4.90
Day$4.81–5.75
52W close$2.78–47.60
Avg vol 30d45K
Short int22K · 0.5% float · 1.0d
Short vol63%
Last earningsMay 14, 2024
DataAug 2022–Oct 2026
Filing10-Q · Sep 24
Up next
filed Sep 24, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$10.26M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
0.2
Trailing earnings · reciprocal yield 538.9%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+801.5%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.5%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−31%
below
Price vs 50-day avg
+45%
above
RSI (14)
75
overbought
MACD trend
Positive
52-week position
6%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+57%
trailing
6-month return
−46%
trailing
YTD return
−69%
this year
Relative strength
−55%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $8 — 200d above 50d
Institutional flow
Distributing
-38% holders QoQ · +3 funds added
Insider flow
Distributing
Net -$372.7K over 90 days · 100% sells
Short interest
Falling
0.46% of float · ▼ -44.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — mid 3-yr range
Squeeze score
40
low risk · 0–100
Fundamentals
EPS growth
+91%
Y/Y
Free cash flow
$-9.5M
Balance sheet
$413.7K
net cash
Quant / Vol
risk profile
Volatility
142%
annualized · 1-yr
Max drawdown
−94%
past year
ATR
7.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the 8-K filed Feb 17, 2026
Research and development expense
· year ended December 31, 2025
$3.4M – $3.9M
General and administrative expenses
· year ended December 31, 2025
$5.2M – $5.8M
Legal and professional expenses
· year ended December 31, 2025
$2.1M – $2.3M
Total current assets
· As of December 31, 2025
$500,000
Total other expense
· year ended December 31, 2025
$100,000 – $200,000
Total current liabilities
· As of December 31, 2025
$1.2M – $1.3M
Working capital deficit
· As of December 31, 2025
$700,000 – $800,000
Contingent consideration
· As of December 31, 2025
$2M
Intangible assets, net
· As of December 31, 2025
$9.8M
Consideration payable
· As of December 31, 2025
$4.4M
Other assets
· As of December 31, 2025
$200,000
Operating lease liability
· As of December 31, 2025
$200,000
Notes payable and accrued interest
· As of December 31, 2025
$0
Convertible notes payable
· As of December 31, 2025
$0
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−31%
Bearish
Price vs 50-day avg
+45%
Bullish
RSI (14)
75
Bearish
MACD trend
Positive
Bullish
52-week position
6%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $8 — 200d above 50d
Institutional flow
Distributing
-38% holders QoQ · +3 funds added
Insider flow
Distributing
Net -$372.7K over 90 days · 100% sells
Short interest
Falling
0.46% of float · ▼ -44.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $6 · 6%
Range high $48
vs 200-day avg -31%
vs 50-day avg +45%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SHPH
this stock
Shuttle Pharmaceuticals Holdings, Inc.
|
$26.44M | — | — | — | 0.5% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$59.16B | +18.8% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$45.83B | -5.0% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$45.74B | +25.8% | +4.3% | 64.3 | 2.7% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$41.48B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SHPH | +40.5% | +57.2% | -45.6% | +37.4% | -69.2% |
| SPY | +1.3% | +2.1% | +9.0% | +1.5% | +13.5% |
| vs SPY | +39.2% | +55.1% | -54.6% | +35.9% | -82.7% |